Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models-Reference-Cited by-同舟云学术

Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models

Published:2004-06 Issue:5 Volume:15 Page:503-512
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Higgins Brian,Kolinsky Kenneth,Smith Melissa,Beck Gordon,Rashed Mohammad,Adames Violeta,Linn Michael,Wheeldon Eric,Gand Laurent,Birnboeck Herbert,Hoffmann Gerhard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference18 articles.

1. Anti-epidermal growth factor receptor drugs in cancer therapy;Ciardiello;Expert Opin Invest Drugs,2002

2. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

3. A review of the pharmacology and clinical activity of new chemotherapeutic agents in lung cancer;Rajkumar;Cancer Treat Rev,1998

4. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions;Bunn;Clin Cancer Res,1998

5. Single-agent gemcitabine: an active and better-tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer;ten Bokkel Huinink;Lung Cancer,1999

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors;Current Topics in Medicinal Chemistry;2023-12

2. Design and Synthesis of Some New Quinoxaline-1,2,4-Oxadiazole-Amide Conjugates as EGFR Targeting Agents and ADMET Studies;Polycyclic Aromatic Compounds;2023-10-09

3. A Drug–Drug Interaction Study to Evaluate the Impact of Simvastatin and Itraconazole on Erlotinib Pharmacokinetics in Rats by UPLC-MS/MS;Drug Design, Development and Therapy;2023-10

4. New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis, In silico Studies, and Anti-proliferative Assessment;Medicinal Chemistry;2023-06

5. Transition-metal-catalyzed synthesis of quinazolines: A review;Frontiers in Chemistry;2023-03-16